 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bafna Pharma Standalone June 2023 Net Sales at Rs 41.95 crore, up 147.81% Y-o-Y

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 August 2023.

Bafna Pharmaceuticals schedules board meeting

Bafna Pharma Standalone March 2023 Net Sales at Rs 42.24 crore, up 181.96% Y-o-Y

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 April 2023.

Bafna Pharmaceuticals to conduct board meeting

Bafna Pharma Standalone December 2022 Net Sales at Rs 34.22 crore, up 67.25% Y-o-Y

Bafna Pharma Standalone June 2022 Net Sales at Rs 16.93 crore, down 20.38% Y-o-Y

Bafna Pharmaceuticals Ltd. engages in the manufacture of drugs and medicines of life saving drugs. Its brand portfolio includes Raricap, Raricap Forte, Raricap L Suspension and Raricap Combi. The company was founded in 1981 and is headquartered in Chennai, India.

Watchers	2
52-Wk Low	77.05
52-Wk High	124.45

Market Cap	2.08B
Volume (M)	5,504.00
52-Wk High	124.45
52-Wk Low	77.05

BAFNAPH.NSE Bafna Pharmaceuticals Ltd

About

Feed

News

Fundamentals